Literature DB >> 27002316

Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.

Kensuke Shiraishi1, Kousaku Mimura1, Ley-Fang Kua2, Vivien Koh2, Lim Kee Siang3, Shotaro Nakajima3, Hideki Fujii4, Asim Shabbir1, Wei-Peng Yong2, Jimmy So1, Seiichi Takenoshita5, Koji Kono6,7,8,9.   

Abstract

BACKGROUND AND METHODS: Natural killer (NK) cells can react with tumor cells through the balance of inhibitory and stimulatory signals between NK cell surface receptors and their ligands, such as MHC class I chain-related A (MICA), MHC class I chain-related B (MICB), and several UL16-binding proteins (ULBPs). In the present study, we evaluated the relationship between NKG2D ligand expression and matrix metalloproteinase (MMP) activity in in vitro culture systems of a panel of gastric cancer cell lines (n = 10) and clinical samples (n = 102).
RESULTS: First, the surface expression of NK group 2 member D (NKG2D) ligands (MICA, MICB, ULBP-2, and ULBP-3) on tumor cells was markedly downregulated on in vitro culture, in parallel to the upregulation of MMPs analyzed by gelatin zymography and gene expression microarray, whereas the transcript levels of NKG2D ligands remained unchanged on in vitro culture. Second, MMP-specific inhibitors could restore the downregulated expression of NKG2D ligands and functionally improve susceptibilities to NK cells in vitro. Third, the production of soluble NKG2D ligands was increased on in vitro culture and was inhibited by MMP-specific inhibitors. Finally, there was a significant inverse correlation between MMP-9 expression and NKG2D ligand expression as analyzed by immunohistochemistry in clinical tumor samples.
CONCLUSION: The present study is a comprehensive study demonstrating that upregulation of MMP activity can induce a downregulation of expression of NKG2D ligands in gastric cancer cells, leading to lower-level susceptibility to NK cells.

Entities:  

Keywords:  Gastric cancer; MHC class I chain-related A/MHC class I chain-related B; Matrix metalloproteinases; Natural killer cells; UL16-binding proteins

Mesh:

Substances:

Year:  2016        PMID: 27002316     DOI: 10.1007/s00535-016-1197-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  36 in total

Review 1.  Matrix metalloproteinases: they're not just for matrix anymore!

Authors:  L J McCawley; L M Matrisian
Journal:  Curr Opin Cell Biol       Date:  2001-10       Impact factor: 8.382

2.  HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.

Authors:  Riki Okita; Dimitrios Mougiakakos; Takashi Ando; Yumeng Mao; Dhifaf Sarhan; Erik Wennerberg; Barbara Seliger; Andreas Lundqvist; Kousaku Mimura; Rolf Kiessling
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

3.  Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.

Authors:  Cristina Cerboni; Alessandra Zingoni; Marco Cippitelli; Mario Piccoli; Luigi Frati; Angela Santoni
Journal:  Blood       Date:  2007-04-03       Impact factor: 22.113

Review 4.  Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

Authors:  Lorenzo Moretta; Franco Locatelli; Daniela Pende; Emanuela Marcenaro; Maria Cristina Mingari; Alessandro Moretta
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

5.  Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms.

Authors:  Hiromi Fujita; Yutaka Hatanaka; Yoichi Sutoh; Yuta Suzuki; Koji Oba; Kanako C Hatanaka; Tomoko Mitsuhashi; Noriyuki Otsuka; Kazunori Fugo; Masanori Kasahara; Yoshihiro Matsuno
Journal:  J Histochem Cytochem       Date:  2014-12-03       Impact factor: 2.479

6.  Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.

Authors:  Keisuke Kohga; Tetsuo Takehara; Tomohide Tatsumi; Takuya Miyagi; Hisashi Ishida; Kazuyoshi Ohkawa; Tatsuya Kanto; Naoki Hiramatsu; Norio Hayashi
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

Review 7.  Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.

Authors:  Ahmed El-Gazzar; Veronika Groh; Thomas Spies
Journal:  J Immunol       Date:  2013-08-15       Impact factor: 5.422

8.  Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer.

Authors:  Karin Söderlund Leifler; Susanne Svensson; Annelie Abrahamsson; Christina Bendrik; Jennifer Robertson; Jack Gauldie; Anna-Karin Olsson; Charlotta Dabrosin
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

9.  Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.

Authors:  Noemi Eiró; Belen Fernandez-Garcia; Luis O González; Francisco J Vizoso
Journal:  Oncoimmunology       Date:  2013-05-01       Impact factor: 8.110

Review 10.  The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells.

Authors:  Cristina Cerboni; Cinzia Fionda; Alessandra Soriani; Alessandra Zingoni; Margherita Doria; Marco Cippitelli; Angela Santoni
Journal:  Front Immunol       Date:  2014-01-07       Impact factor: 7.561

View more
  15 in total

Review 1.  Role of NKG2D and its ligands in cancer immunotherapy.

Authors:  Huifang Liu; Sijia Wang; Jing Xin; Jing Wang; Cuiping Yao; Zhenxi Zhang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

2.  Differential modulation of natural killer cell cytotoxicity by 17β-estradiol and prolactin through the NKG2D/NKG2DL axis in cervical cancer cells.

Authors:  Alejandro Godoy-Pacheco; Mariel García-Chagollán; Adrián Ramírez-De-Arellano; Christian David Hernández-Silva; Julio César Villegas-Pineda; Inocencia Guadalupe Ramírez-López; José Sergio Zepeda-Nuño; Adriana Aguilar-Lemarroy; Ana Laura Pereira-Suárez
Journal:  Oncol Lett       Date:  2022-06-28       Impact factor: 3.111

3.  Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?

Authors:  Juan Wang; Emilien Loeuillard; Gregory J Gores; Sumera I Ilyas
Journal:  Expert Opin Ther Targets       Date:  2021-12-03       Impact factor: 6.797

4.  Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion.

Authors:  Linda Ziani; Thouraya Ben Safta-Saadoun; Johanne Gourbeix; Andrea Cavalcanti; Caroline Robert; Gilles Favre; Salem Chouaib; Jerome Thiery
Journal:  Oncotarget       Date:  2017-03-21

Review 5.  The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.

Authors:  Giovanni Barillari
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

Review 6.  NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.

Authors:  Alexandra Frazao; Louise Rethacker; Meriem Messaoudene; Marie-Françoise Avril; Antoine Toubert; Nicolas Dulphy; Anne Caignard
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 7.  Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors Surveillance.

Authors:  Elisa Ferretti; Simona Carlomagno; Silvia Pesce; Letizia Muccio; Valentina Obino; Marco Greppi; Agnese Solari; Chiara Setti; Emanuela Marcenaro; Mariella Della Chiesa; Simona Sivori
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

8.  Downregulation of NKG2DLs by TGF-β in human lung cancer cells.

Authors:  Young Shin Lee; Hojung Choi; Hae-Ryung Cho; Woo-Chang Son; You-Soo Park; Chi-Dug Kang; Jaeho Bae
Journal:  BMC Immunol       Date:  2021-07-12       Impact factor: 3.615

Review 9.  NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy.

Authors:  Dominik Schmiedel; Ofer Mandelboim
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

Review 10.  Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.

Authors:  Gustavo Rodrigues Rossi; Edvaldo S Trindade; Fernando Souza-Fonseca-Guimaraes
Journal:  Front Immunol       Date:  2020-01-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.